相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Wenzel M. Hackeng et al.
GUT (2022)
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
Jun Uemura et al.
ANNALS OF SURGERY (2021)
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Chang Colin Tan et al.
CANCER COMMUNICATIONS (2020)
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
Mauro Cives et al.
SCIENTIFIC REPORTS (2019)
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
Somak Roy et al.
GASTROENTEROLOGY (2018)
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors
Angela Chou et al.
HUMAN PATHOLOGY (2018)
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability
Nitya Raj et al.
JCO PRECISION ONCOLOGY (2018)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
Joo Kyung Park et al.
ONCOTARGET (2017)
Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
Christodoulos P. Pipinikas et al.
ENDOCRINE-RELATED CANCER (2015)
Emerging roles of ATRX in cancer
L. Ashley Watson et al.
EPIGENOMICS (2015)
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
David Clynes et al.
NATURE COMMUNICATIONS (2015)
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies
Michelle D. Reid et al.
MODERN PATHOLOGY (2015)
A systematic review of non-surgical treatments for pancreatic neuroendOcrine tumours
Juan W. Valle et al.
CANCER TREATMENT REVIEWS (2014)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neuroendocrine Tumors
Fei Yuan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Impact of the tumor microenvironment in predicting postoperative hepatic recurrence of pancreatic neuroendocrine tumors
Shoki Sato et al.
ONCOLOGY REPORTS (2014)
Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size
Eric J. Kuo et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Current Understanding of the Molecular Biology of Pancreatic Neuroendocrine Tumors
Jianliang Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians
Jaya Sharma et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Relapse-Free Survival in Patients With Nonmetastatic, Surgically Resected Pancreatic Neuroendocrine Tumors An Analysis of the AJCC and ENETS Staging Classifications
Jonathan R. Strosberg et al.
ANNALS OF SURGERY (2012)
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Courtney A. Lovejoy et al.
PLOS GENETICS (2012)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Aaron D. Goldberg et al.
CELL (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients
Jan Franko et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
Peter W. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors - Analysis of 3851 patients
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2008)
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Thorvardur R. Halfdanarson et al.
ENDOCRINE-RELATED CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
Simon Sanderson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)
Neuroendocrine tumours of the pancreas: Predictors of survival after surgical treatment
NP Jarufe et al.
DIGESTIVE SURGERY (2005)
Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the α-thalassemia myelodysplasia syndrome (ATMDS)
RJ Gibbons et al.
NATURE GENETICS (2003)
Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy
FJ Song et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)